Xemed LLC   Report issue

For profit Phase 1 Phase 2
Founded: Durham NH United States (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2011
NCT02163681
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Xemed LLC